You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Efficacy and safety of tapentadol prolonged release for chronic osteoarthritis pain and low back pain
|
|---|---|
| Published in |
Advances in Therapy, June 2010
|
| DOI | 10.1007/s12325-010-0036-3 |
| Pubmed ID | |
| Authors |
Bernd Lange, Brigitte Kuperwasser, Akiko Okamoto, Achim Steup, Thomas Häufel, Judy Ashworth, Mila Etropolski |
| Abstract |
This pooled analysis of data from three phase 3 studies in patients with chronic osteoarthritis knee or low back pain evaluated the efficacy and tolerability of tapentadol prolonged release (PR; 100-250 mg twice daily) compared with placebo and oxycodone hydrochloride (HCl) controlled release (CR; 20-50 mg twice daily). |
X Demographics
The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 1 | 25% |
| Unknown | 3 | 75% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Practitioners (doctors, other healthcare professionals) | 2 | 50% |
| Science communicators (journalists, bloggers, editors) | 1 | 25% |
| Members of the public | 1 | 25% |
Mendeley readers
The data shown below were compiled from readership statistics for 155 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 2 | 1% |
| United States | 1 | <1% |
| Norway | 1 | <1% |
| Argentina | 1 | <1% |
| Unknown | 150 | 97% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Other | 28 | 18% |
| Researcher | 26 | 17% |
| Student > Master | 15 | 10% |
| Student > Bachelor | 14 | 9% |
| Student > Ph. D. Student | 12 | 8% |
| Other | 30 | 19% |
| Unknown | 30 | 19% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 69 | 45% |
| Psychology | 9 | 6% |
| Pharmacology, Toxicology and Pharmaceutical Science | 9 | 6% |
| Nursing and Health Professions | 9 | 6% |
| Agricultural and Biological Sciences | 6 | 4% |
| Other | 21 | 14% |
| Unknown | 32 | 21% |
Attention Score in Context
This research output has an Altmetric Attention Score of 15. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 02 December 2019.
All research outputs
#2,170,989
of 23,577,761 outputs
Outputs from Advances in Therapy
#180
of 2,410 outputs
Outputs of similar age
#7,830
of 97,394 outputs
Outputs of similar age from Advances in Therapy
#2
of 9 outputs
Altmetric has tracked 23,577,761 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 90th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,410 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 7.8. This one has done particularly well, scoring higher than 92% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 97,394 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 91% of its contemporaries.
We're also able to compare this research output to 9 others from the same source and published within six weeks on either side of this one. This one has scored higher than 7 of them.